0534384 - ÚOCHB 2021 RIV chi P - Patent Document
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
喹唑啉化合物.
[Quinazoline compounds.]
2020. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 21.07.2020. Patent Number: TWI699355
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=TW&NR=I699355B&KC=B&FT=D&ND=4&date=20200721&DB=&locale=en_EP
Permanent Link: http://hdl.handle.net/11104/0312833
Jansa, Petr - Šimon, Petr - Lansdon, E. - Hu, Y. E. - Baszczyňski, Ondřej - Dejmek, Milan - Mackman, R.
喹唑啉化合物.
[Quinazoline compounds.]
2020. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 21.07.2020. Patent Number: TWI699355
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=TW&NR=I699355B&KC=B&FT=D&ND=4&date=20200721&DB=&locale=en_EP
Permanent Link: http://hdl.handle.net/11104/0312833